Last update :
28/04/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Antihistamine (H2)   Famotidine  
Injection
Oral solution
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Anfamox Australia
Facid India
Famodil Italy
Famotidina Chile
Famotidine Canada, United States of America
Femidin India
Gaster Japan
Gastrium Chile
Kinotal Venezuela
Motiax Italy
Nevofam - L Turkey
Pepcidine Australia, Luxembourg, Netherlands
Pepdine Morocco
Quamatel Hungary, Poland, Romania
Ulcusan Austria
Stability of mixtures   Injection   Stability of mixtures : Famotidine     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Glass Glucose 5% 1 mg/ml
Injection   Famotidine   
Injection   Palonosetron hydrochloride 25 µg/ml
25°C
4 Hour
Light 2279
Level of evidence A+
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0.1 & 2 mg/ml
Injection   Famotidine   
Injection   Tirofiban 25 µg/ml
25°C
4 Hour
Light 1420
Level of evidence C+
Polyvinyl chloride Glucose 5% 0,08 mg/ml
Injection   Famotidine   
Injection   Flumazenil 0,02 mg/ml
23°C
24 Hour
Light 187
Level of evidence A
Polypropylen Syringe Sodium chloride 0,9% 0,4 mg/ml
Injection   Famotidine   
Injection   Scopolamine hydrobromide 0,04 mg/ml
Injection   Haloperidol lactate 0,5 mg/ml
Injection   Dimenhydrinate 5 mg/ml
Injection   Hydromorphone hydrochloride 10 mg/ml
25°C
12 Hour
Not specified 2166
Polypropylen Syringe Sodium chloride 0,9% 0,4 mg/ml
Injection   Famotidine   
Injection   Midazolam hydrochloride 1 mg/ml
Injection   Hydromorphone hydrochloride 10 mg/ml
25°C
96 Hour
Not specified 2166
Polypropylen Syringe Sodium chloride 0,9% 0,4 mg/ml
Injection   Famotidine   
Injection   Metoclopramide hydrochloride 0,5 mg/ml
Suppository   Ketoprofene   
Injection   Hydromorphone hydrochloride 10 mg/ml
25°C
96 Hour
Not specified 2166
Polypropylen Syringe Sodium chloride 0,9% 0,4 mg/ml
Injection   Famotidine   
Injection   Scopolamine hydrobromide 0,04 mg/ml
Injection   Haloperidol lactate 0,5 mg/ml
Injection   Dimenhydrinate 5 mg/ml
Injection   Hydromorphone hydrochloride 10 mg/ml
4°C
12 Hour
Not specified 2166
Polypropylen Syringe Sodium chloride 0,9% 0,4 mg/ml
Injection   Famotidine   
Injection   Midazolam hydrochloride 1 mg/ml
Injection   Hydromorphone hydrochloride 10 mg/ml
4°C
96 Hour
Not specified 2166
Polypropylen Syringe Sodium chloride 0,9% 0,4 mg/ml
Injection   Famotidine   
Injection   Metoclopramide hydrochloride 0,5 mg/ml
Injection   Ketorolac tromethamine 1,5 mg/ml
Injection   Hydromorphone hydrochloride 10 mg/ml
4°C
96 Hour
Not specified 2166
Not specified Glucose 5% 0,2 mg/ml
Injection   Famotidine   
Injection   Vancomycin hydrochloride 0,5 mg/ml
25°C
14 Day
Protect from light 1748
Level of evidence B
Not specified Glucose 5% 0,2 mg/ml
Injection   Famotidine   
Injection   Cefmetazole sodium 5 mg/ml
25°C
5 Day
Not specified 237
Level of evidence B
Not specified Glucose 5% 0,2 mg/ml
Injection   Famotidine   
Injection   Cefmetazole sodium 5 mg/ml
4°C
7 Day
Protect from light 237
Level of evidence B
Not specified Glucose 5% 0,2 mg/ml
Injection   Famotidine   
Injection   Vancomycin hydrochloride 0,5 mg/ml
4°C
14 Day
Protect from light 1748
Level of evidence B
  Mentions Légales